While hormone replacement therapy (HRT) is not broadly linked to young-onset breast cancer, using certain types before menopause could increase the risk of it developing in young women, a new study ...

HRT does not increase breast cancer risk in BRCA1/BRCA2 variant carriers, with lower incidence in users versus non-users. Estrogen-alone therapy is linked to reduced mortality, while estrogen plus ...

The risks and benefits of hormone replacement therapy use for menopausal symptoms in breast cancer survivors are examined in light of recent research. Recent changes to the warning labels on hormone ...

Using some types of HRT before the menopause could increase the risk of breast cancer in young women, a study suggests. The research found that overall the use of hormone replacement therapy (HRT) was ...

For decades, breast cancer survivors going through menopause have been told that hormone therapy is off-limits—full stop. But new analyses and a 2025 expert consensus paper suggest that there may be ...

Breast cancer survivors with severe menopausal symptoms should be supported to make an informed decision about whether to have hormone replacement therapy or not, according to an interdisciplinary ...

More physicians are discussing hormone replacement therapy with breast cancer survivors when menopause hits.

Hormone therapy for breast cancer is not the same as hormone replacement therapy at menopause, in which hormones are given to reduce the symptoms that can be associated with menopause.

Cortisol is bad. Testosterone makes you aggressive. Melatonin helps you sleep. Experts bust common hormone myths ...